Login / Signup

Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL): a randomised, multi-centre phase II trial.

Karthik RamasamyGulnaz IqbalRichard BrouwerVictoria StalkerSalma AkhtarSherin VargheseJindriska LindsayStephen ScheyMark T DraysonJanet Dunn
Published in: Blood cancer journal (2022)
Keyphrases
  • multiple myeloma
  • open label
  • high dose
  • low dose
  • clinical trial
  • newly diagnosed
  • placebo controlled
  • chronic lymphocytic leukemia
  • double blind
  • study protocol
  • randomized controlled trial